💊 Препараты А-Я 🧬 Мишени 🛠 Инструменты 📚 Руководства
Все препараты Классы препаратов Терапевтические области Побочные Эффекты
Руководства Глоссарий Хронология
Сравнения Путешествия препаратов Группы лекарственных средств
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Polidocanol

CHEMBL6067961 Phase 4 Одобрено Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
582.8 g/mol
LogP
3.9
Phase
4

Polidocanol is a sclerosant agent and local anesthetic belonging to the fatty alcohol polyethylene oxide class that causes endothelial cell injury and subsequent fibrosis when injected into blood vessels or varicose veins. It is used for sclerotherapy of varicose veins, esophageal varices, and hemorrhoids, and has also been used topically as a mild local anesthetic for pruritis relief.

Молекулярная масса

582,8000 g/mol

LogP

3,90

TPSA

103,00 Ų

Правило пяти Липинского

Соответствует

Терапевтические области

Melanoma Gastroesophageal Reflux Disease Hypertension

Механизм действия

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

SMILES

CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3

Molecular Formula

C30H62O10

HBD / HBA

1 / 10

Вращаемые Связи

37

Тяжёлые Атомы

40

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

Polidocanol is a sclerosant agent and local anesthetic belonging to the fatty alcohol polyethylene oxide class that causes endothelial cell injury and subsequent fibrosis when injected into blood vessels or varicose veins. It is used for sclerotherapy of varicose veins, esophageal varices, and hemorrhoids, and has also been used topically as a mild local anesthetic for pruritis relief.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Polidocanol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067961. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 656641. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.